Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors

Abstract To present the feasibility of a dynamic whole-body (DWB) 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors (WD-NETs). Sixty-one patients who underwent a DWB 68Ga-DOTATOC-PET/CT for a histologically proven/highly suspected WD-NET were prospectively in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Philippe Thuillier, David Bourhis, Jean Philippe Metges, Romain Le Pennec, Karim Amrane, Ulrike Schick, Frédérique Blanc-Beguin, Simon Hennebicq, Pierre-Yves Salaun, Véronique Kerlan, Nicolas Karakatsanis, Ronan Abgral
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d39da825f175412f822a6780af2476cf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d39da825f175412f822a6780af2476cf
record_format dspace
spelling oai:doaj.org-article:d39da825f175412f822a6780af2476cf2021-12-02T13:20:04ZProspective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors10.1038/s41598-021-83965-92045-2322https://doaj.org/article/d39da825f175412f822a6780af2476cf2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83965-9https://doaj.org/toc/2045-2322Abstract To present the feasibility of a dynamic whole-body (DWB) 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors (WD-NETs). Sixty-one patients who underwent a DWB 68Ga-DOTATOC-PET/CT for a histologically proven/highly suspected WD-NET were prospectively included. The acquisition consisted in single-bed dynamic acquisition centered on the heart, followed by the DWB and static acquisitions. For liver, spleen and tumor (1–5/patient), Ki values (in ml/min/100 ml) were calculated according to Patlak's analysis and tumor-to-liver (TLR-Ki) and tumor-to-spleen ratios (TSR-Ki) were recorded. Ki-based parameters were compared to static parameters (SUVmax/SUVmean, TLR/TSRmean, according to liver/spleen SUVmean), in the whole-cohort and according to the PET system (analog/digital). A correlation analysis between SUVmean/Ki was performed using linear and non-linear regressions. Ki-liver was not influenced by the PET system used, unlike SUVmax/SUVmean. The regression analysis showed a non-linear relation between Ki/SUVmean (R2 = 0.55,0.68 and 0.71 for liver, spleen and tumor uptake, respectively) and a linear relation between TLRmean/TLR-Ki (R2 = 0.75). These results were not affected by the PET system, on the contrary of the relation between TSRmean/TSR-Ki (R2 = 0.94 and 0.73 using linear and non-linear regressions in digital and analog systems, respectively). Our study is the first showing the feasibility of a DWB 68Ga-DOTATOC-PET/CT acquisition in WD-NETs.Philippe ThuillierDavid BourhisJean Philippe MetgesRomain Le PennecKarim AmraneUlrike SchickFrédérique Blanc-BeguinSimon HennebicqPierre-Yves SalaunVéronique KerlanNicolas KarakatsanisRonan AbgralNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Philippe Thuillier
David Bourhis
Jean Philippe Metges
Romain Le Pennec
Karim Amrane
Ulrike Schick
Frédérique Blanc-Beguin
Simon Hennebicq
Pierre-Yves Salaun
Véronique Kerlan
Nicolas Karakatsanis
Ronan Abgral
Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
description Abstract To present the feasibility of a dynamic whole-body (DWB) 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors (WD-NETs). Sixty-one patients who underwent a DWB 68Ga-DOTATOC-PET/CT for a histologically proven/highly suspected WD-NET were prospectively included. The acquisition consisted in single-bed dynamic acquisition centered on the heart, followed by the DWB and static acquisitions. For liver, spleen and tumor (1–5/patient), Ki values (in ml/min/100 ml) were calculated according to Patlak's analysis and tumor-to-liver (TLR-Ki) and tumor-to-spleen ratios (TSR-Ki) were recorded. Ki-based parameters were compared to static parameters (SUVmax/SUVmean, TLR/TSRmean, according to liver/spleen SUVmean), in the whole-cohort and according to the PET system (analog/digital). A correlation analysis between SUVmean/Ki was performed using linear and non-linear regressions. Ki-liver was not influenced by the PET system used, unlike SUVmax/SUVmean. The regression analysis showed a non-linear relation between Ki/SUVmean (R2 = 0.55,0.68 and 0.71 for liver, spleen and tumor uptake, respectively) and a linear relation between TLRmean/TLR-Ki (R2 = 0.75). These results were not affected by the PET system, on the contrary of the relation between TSRmean/TSR-Ki (R2 = 0.94 and 0.73 using linear and non-linear regressions in digital and analog systems, respectively). Our study is the first showing the feasibility of a DWB 68Ga-DOTATOC-PET/CT acquisition in WD-NETs.
format article
author Philippe Thuillier
David Bourhis
Jean Philippe Metges
Romain Le Pennec
Karim Amrane
Ulrike Schick
Frédérique Blanc-Beguin
Simon Hennebicq
Pierre-Yves Salaun
Véronique Kerlan
Nicolas Karakatsanis
Ronan Abgral
author_facet Philippe Thuillier
David Bourhis
Jean Philippe Metges
Romain Le Pennec
Karim Amrane
Ulrike Schick
Frédérique Blanc-Beguin
Simon Hennebicq
Pierre-Yves Salaun
Véronique Kerlan
Nicolas Karakatsanis
Ronan Abgral
author_sort Philippe Thuillier
title Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
title_short Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
title_full Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
title_fullStr Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
title_full_unstemmed Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
title_sort prospective study of dynamic whole-body 68ga-dotatoc-pet/ct acquisition in patients with well-differentiated neuroendocrine tumors
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d39da825f175412f822a6780af2476cf
work_keys_str_mv AT philippethuillier prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT davidbourhis prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT jeanphilippemetges prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT romainlepennec prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT karimamrane prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT ulrikeschick prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT frederiqueblancbeguin prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT simonhennebicq prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT pierreyvessalaun prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT veroniquekerlan prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT nicolaskarakatsanis prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT ronanabgral prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
_version_ 1718393241333661696